Chimenti C, Pieroni M, Morgante E, Antuzzi D, et al. Prevalence of Fabry disease in
female patients with late-onset hypertrophic cardiomyopathy. Circulation 2004;110:
1047–1053.
Thadhani R, Wolf M, West ML, Tonelli M, et al. Patients with Fabry disease on
dialysis in the United States. Kidney Int 2002;61:249–255.
Linhart A, Palecek T, Bultas J, Ferguson JJ, et al. New insights in cardiac structural
changes in patients with Fabry's disease. Am Heart J 2000;139:1101–1108.
Ries M, Ramaswami U, Parini R, Lindblad B, et al. The early clinical phenotype of
Fabry disease: a study on 35 European children and adolescents. Eur J Pediatr 2003;
162:767–772.
Maier S, Breunig F, Knoll A, et al. ECG-changes in Fabry disease patients under 12
months of enzyme replacement therapy. German J Cardiology 2004;93 3:166.
Shah J, Mehta A, Hughes D, et al. Arrhythmia in Anderson-Fabry disease. Eur
Heart Journal 2004;25:539.
Cantor WJ, Daly P, Iwanochko M, Clarke JT, et al. Cardiac transplantation for
Fabry's disease. Can J Cardiol 1998;14:81–84.
Cartwright DJ, Cole AL, Cousins AJ, Lee PJ. Raised HDL cholesterol in Fabry disease: response to enzyme replacement therapy. J Inherit Metab Dis 2004;27:791–793.
Amann-Vesti BR, Gitzelmann G, Widmer U, Bosshard NU, et al. Severe lymphatic
microangiopathy in Fabry disease. Lymphat Res Biol 2003;1:185–189.
O'Connor PJ, Gray RJ, Maciosek MV, Fillbrandt KM, et al. Cholesterol levels and
statin use in patients with coronary heart disease treated in primary care settings.
Prev Chronic Dis 2005;2 :A05.
Ko DT, Hebert PR, Coffey CS, Curtis JP, et al. Adverse effects of beta-blocker therapy
for patients with heart failure: a quantitative overview of randomized trials. Arch
Intern Med 2004;164:1389–1394.
Kahn P. Anderson-Fabry disease: a histopathological study of three cases with ob-servations on the mechanism of production of pain. J Neurol Neurosurg Psychiatry
1973;36:1053–1062.
Grewal RP. Stroke in Fabry's disease. J Neurol 1994;241:153–156.
Mitsias P, Levine SR. Cerebrovascular complications of Fabry's disease. Ann Neurol
1996;40:8–17.
Jardim L, Vedolin L, Schwartz IV, Burin MG, et al. CNS involvement in Fabry
disease: clinical and imaging studies before and after 12 months of enzyme replacement therapy. J Inherit Metab Dis 2004;27:229–240.
Mendez MF, Stanley TM, Medel NM, Li Z, et al. The vascular dementia of Fabry's
disease. Dement Geriatr Cogn Disord 1997;8:252–257.
MacDermot J, MacDermot KD. Neuropathic pain in Anderson-Fabry disease: pa-thology and therapeutic options. Eur J Pharmacol 2001;429:121–125.
Shelley ED, Shelley WB, Kurczynski TW. Painful fingers, heat intolerance, and telangiectases of the ear: easily ignored childhood signs of Fabry disease. Pediatr Dermatol 1995;12:215–219.
Yamamoto K, Sobue G, Iwase S, Kumazawa K, et al. Possible mechanism of anhidrosis in a symptomatic female carrier of Fabry's disease: an assessment by skin sympathetic nerve activity and sympathetic skin response. Clin Auton Res 1996;6:107–110.
Hilz MJ. Evaluation of peripheral and autonomic nerve function in Fabry disease.
Acta Paediatr Suppl 2002;91:38–42.
Germain D, Avan P, Chassaing A, Bonfils P. Patients affected with Fabry disease have
an increased incidence of progressive hearing loss and sudden deafness: A study of
twenty-two hemizygous male patients. BMC Medical Genetics 2002;3:10.
Bird TD, Lagunoff D. Neurological manifestations of Fabry disease in female carriers. Ann Neurol 1978;4:537–540.
De Groot W. Angiokeratoma corporis diffusum Fabry. Dermatologica 1964;128:
321–349.
Morgan SH, Rudge P, Smith SJ, Bronstein AM, et al. The neurological complications
of Anderson-Fabry disease (alpha- galactosidase A deficiency)–investigation of
symptomatic and presymptomatic patients. Q J Med 1990;75 (277):491–507.
MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet
2001;38:750–760.
Banikazemi M, Ullman T, Desnick RJ. Gastrointestinal manifestations of Fabry
disease: Clinical response to enzyme replacement therapy. Mol Genet Metab 2005;
85:255–259.
Nelis GF, Jacobs GJ. Anorexia, weight loss, and diarrhea as presenting symptoms of
angiokeratoma corporis diffusum (Fabry-Anderson's disease). Dig Dis Sci 1989;34:
1798–1800.
Sheth KJ, Werlin SL, Freeman ME, Hodach AE. Gastrointestinal structure and function in Fabry's disease. Am J Gastroenterol 1981;76:246–251.
Ries M, Gupta S, Moore DF, Sachdev V, et al. Pediatric Fabry disease. Pediatrics
2005;115:E344–E355.
Mehta A, Ricci R, Widmer U, Dehout F, et al. Fabry disease defined: baseline clinical
manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 2004;
34:236–242.
